World Wires · story 32247 · unverified · 1 source(s)

Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease

Company common stock to trade on Nasdaq under the symbol “IRLA” effective October 12, 2026

Open in the desk

Coverage

• Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease GlobeNewswire: public companies · tier D · clear net · 2026-10-09 12:00 UTC

What this site indexes